BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
8.66 / 10
Outperform
Analyst view is overwhelmingly bullish: 1 Buy recommendation (100%) with a 75% historical win rate and weighted rating 9.66. Fund‑flow score 7.65 indicates strong inflows, especially from large and extra‑large investors, though small‑mid flows are weaker.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionRBC Capital
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of BCRX?
- BCRX holds a Bullish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.66/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
